HomeCompareHLBBF vs MCD

HLBBF vs MCD: Dividend Comparison 2026

HLBBF yields 2.10% · MCD yields 2.34%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MCD wins by $57.7K in total portfolio value
10 years
HLBBF
HLBBF
● Live price
2.10%
Share price
$6.18
Annual div
$0.13
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$0.21
Full HLBBF calculator →
MCD
McDonald's Corporation
● Live price
2.34%
Share price
$310.79
Annual div
$7.26
5Y div CAGR
42.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$77.7K
Annual income
$25,833.37
Full MCD calculator →

Portfolio growth — HLBBF vs MCD

📍 MCD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHLBBFMCD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HLBBF + MCD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HLBBF pays
MCD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HLBBF
Annual income on $10K today (after 15% tax)
$178.66/yr
After 10yr DRIP, annual income (after tax)
$0.18/yr
MCD
Annual income on $10K today (after 15% tax)
$198.56/yr
After 10yr DRIP, annual income (after tax)
$21,958.36/yr
At 15% tax rate, MCD beats the other by $21,958.19/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HLBBF + MCD for your $10,000?

HLBBF: 50%MCD: 50%
100% MCD50/50100% HLBBF
Portfolio after 10yr
$48.9K
Annual income
$12,916.79/yr
Blended yield
26.42%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCD right now

HLBBF
No analyst data
Altman Z
2.1
Piotroski
5/9
MCD
Analyst Ratings
37
Buy
23
Hold
1
Sell
Consensus: Buy
Price Target
$351.76
+13.2% upside vs current
Range: $320.00 — $385.00
Altman Z
4.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HLBBF buys
0
MCD buys
0
No recent congressional trades found for HLBBF or MCD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHLBBFMCD
Forward yield2.10%2.34%
Annual dividend / share$0.13$7.26
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%42.3%
Portfolio after 10y$20.0K$77.7K
Annual income after 10y$0.21$25,833.37
Total dividends collected$211.00$57.7K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: HLBBF vs MCD ($10,000, DRIP)

YearHLBBF PortfolioHLBBF Income/yrMCD PortfolioMCD Income/yrGap
1← crossover$10,805$105.09$10,812$332.41$7.00MCD
2$11,615$53.06$11,819$488.02$204.00MCD
3$12,454$26.65$13,111$724.37$657.00MCD
4$13,339$13.36$14,832$1,091.05$1.5KMCD
5$14,280$6.68$17,219$1,675.85$2.9KMCD
6$15,283$3.34$20,688$2,641.85$5.4KMCD
7$16,354$1.67$25,990$4,309.70$9.6KMCD
8$17,500$0.84$34,590$7,351.77$17.1KMCD
9$18,725$0.42$49,535$13,285.25$30.8KMCD
10$20,036$0.21$77,746$25,833.37$57.7KMCD

HLBBF vs MCD: Complete Analysis 2026

HLBBFStock

H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Onfi for Lennox-Gastaut syndrome; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership agreement with Verantos to focus on a study to enable real-world evidence in support of migraine therapy; and collaboration with Rgenta Therapeutics, Inc. The company was founded in 1915 and is headquartered in Valby, Denmark.

Full HLBBF Calculator →

MCDConsumer Discretionary

McDonald's Corporation operates and franchises McDonald's restaurants in the United States and internationally. Its restaurants offer hamburgers and cheeseburgers, chicken sandwiches and nuggets, wraps, fries, salads, oatmeal, shakes, desserts, sundaes, soft serve cones, bakery items, soft drinks, coffee, and beverages and other beverages, as well as breakfast menu, including biscuit and bagel sandwiches, breakfast burritos, hotcakes, and other sandwiches. As of December 31, 2021, the company operated 40,031 restaurants. McDonald's Corporation was founded in 1940 and is headquartered in Chicago, Illinois.

Full MCD Calculator →
📬

Get this HLBBF vs MCD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HLBBF vs SCHDHLBBF vs JEPIHLBBF vs OHLBBF vs KOHLBBF vs MAINHLBBF vs YUMHLBBF vs QSRHLBBF vs SBUX

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.